GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 141 filers reported holding GENMAB A/S in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,030,769 | -65.2% | 80,264 | -61.0% | 0.00% | – |
| Q4 2022 | $8,711,124 | +487.4% | 205,548 | +350.2% | 0.00% | – |
| Q2 2022 | $1,483,000 | -80.2% | 45,652 | -77.9% | 0.00% | – |
| Q1 2022 | $7,484,000 | +15.8% | 206,862 | +26.6% | 0.00% | – |
| Q4 2021 | $6,462,000 | +980.6% | 163,338 | +1094.1% | 0.00% | – |
| Q3 2021 | $598,000 | -47.9% | 13,679 | -51.3% | 0.00% | – |
| Q2 2021 | $1,147,000 | +81.5% | 28,096 | +45.9% | 0.00% | – |
| Q1 2021 | $632,000 | -75.8% | 19,257 | -70.1% | 0.00% | – |
| Q4 2020 | $2,616,000 | -24.8% | 64,342 | -32.3% | 0.00% | – |
| Q3 2020 | $3,481,000 | +310.0% | 95,081 | +137.2% | 0.00% | – |
| Q1 2020 | $849,000 | – | 40,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
| Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
| HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
| Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
| Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
| TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
| First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
| Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
| Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |